Overview

A Study of Ultra High Dose Diuretics to Treat Heart Failure

Status:
Enrolling by invitation
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of ultrahigh dose diuretics compared to standard dose diuretics over 24 hours in patients with decompensated heart failure.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Bumetanide
Diuretics
Furosemide